XML 95 R82.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidating Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:        
Net income $ 94,503 $ 207,777 $ 232,662 $ 131,629
Changes in operating assets and liabilities and non-cash items included in net income     712,977 309,902
Net cash provided by operating activities     945,639 441,531
Cash flows from investing activities:        
Additions of property and equipment (185,440) (169,452) (358,627) (290,873)
Acquisitions     (473,314) (45,059)
Proceeds from asset and business sales     17,393 3,415
Proceeds (purchases) from investment sales and other items, net     56,319 (614,820)
Net cash used in investing activities     (758,229) (947,337)
Cash flows from financing activities:        
Long-term debt and related financing costs, net     (61,233) 667,992
Other items     (342,321) (192,899)
Net cash (used in) provided by financing activities     (403,554) 475,093
Effect of exchange rate changes on cash     444 (793)
Net decrease in cash and cash equivalents     (215,700) (31,506)
Cash and cash equivalents at beginning of the year     1,499,116 965,241
Cash and cash equivalents at end of the period 1,283,416 933,735 1,283,416 933,735
Consolidation, Eliminations        
Cash flows from operating activities:        
Net income (182,366) (247,618) (315,109) (159,530)
Changes in operating assets and liabilities and non-cash items included in net income     315,109 159,530
DaVita HealthCare Partners Inc. | Reportable Legal Entities        
Cash flows from operating activities:        
Net income 53,382 170,477 150,816 59,860
Changes in operating assets and liabilities and non-cash items included in net income     (1,505) (117,778)
Net cash provided by operating activities     149,311 (57,918)
Cash flows from investing activities:        
Additions of property and equipment     (42,266) (21,179)
Proceeds (purchases) from investment sales and other items, net     21,230 (604,922)
Net cash used in investing activities     (21,036) (626,101)
Cash flows from financing activities:        
Long-term debt and related financing costs, net     (42,493) 682,510
Intercompany borrowing (payments)     11,208 108,911
Other items     (255,032) (121,059)
Net cash (used in) provided by financing activities     (286,317) 670,362
Net decrease in cash and cash equivalents     (158,042) (13,657)
Cash and cash equivalents at beginning of the year     1,186,636 698,876
Cash and cash equivalents at end of the period 1,028,594 685,219 1,028,594 685,219
Guarantor Subsidiaries | Reportable Legal Entities        
Cash flows from operating activities:        
Net income 35,933 166,972 106,352 33,828
Changes in operating assets and liabilities and non-cash items included in net income     219,697 215,135
Net cash provided by operating activities     326,049 248,963
Cash flows from investing activities:        
Additions of property and equipment     (171,164) (147,637)
Acquisitions     (462,592) (44,740)
Proceeds from asset and business sales     17,393 3,415
Proceeds (purchases) from investment sales and other items, net     (10,869) (833)
Net cash used in investing activities     (627,232) (189,795)
Cash flows from financing activities:        
Long-term debt and related financing costs, net     (13,917) (7,922)
Intercompany borrowing (payments)     247,765 (60,132)
Other items     (6,253) (10,840)
Net cash (used in) provided by financing activities     227,595 (78,894)
Net decrease in cash and cash equivalents     (73,588) (19,726)
Cash and cash equivalents at beginning of the year     109,357 77,921
Cash and cash equivalents at end of the period 35,769 58,195 35,769 58,195
Non-Guarantor Subsidiaries | Reportable Legal Entities        
Cash flows from operating activities:        
Net income 187,554 117,946 290,603 197,471
Changes in operating assets and liabilities and non-cash items included in net income     179,676 53,015
Net cash provided by operating activities     470,279 250,486
Cash flows from investing activities:        
Additions of property and equipment     (145,197) (122,057)
Acquisitions     (10,722) (319)
Proceeds (purchases) from investment sales and other items, net     45,958 (9,065)
Net cash used in investing activities     (109,961) (131,441)
Cash flows from financing activities:        
Long-term debt and related financing costs, net     (4,823) (6,596)
Intercompany borrowing (payments)     (258,973) (48,779)
Other items     (81,036) (61,000)
Net cash (used in) provided by financing activities     (344,832) (116,375)
Effect of exchange rate changes on cash     444 (793)
Net decrease in cash and cash equivalents     15,930 1,877
Cash and cash equivalents at beginning of the year     203,123 188,444
Cash and cash equivalents at end of the period $ 219,053 $ 190,321 $ 219,053 $ 190,321